Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- US stock futures tick higher as tech steadies though oil, yields stay high
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
Vitae Pharmaceuticals (VTAE) Prices 3M Common Follow-On at $11.90/Share
January 23, 2015 7:21 AM ESTVitae Pharmaceuticals (NASDAQ: VTAE) announced the pricing of its follow-on public offering of 3,000,000 shares of its common stock at $11.90 per share. All shares of common stock to be sold in the offering are being offered by Vitae. Vitae has also granted the... More
